Invention Grant
- Patent Title: Antibodies
-
Application No.: US17077376Application Date: 2020-10-22
-
Publication No.: US11008399B2Publication Date: 2021-05-18
- Inventor: David Satijn , Esther C. W. Breij , Bart E. C. G. De Goeij , Kristel Kemper , Patrick Engelberts , Edward N. Van Den Brink , Rik Rademaker , Dennis Verzijl , Sjeng Horbach , Paul Parren
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: EP18161293 20180312,EP18175347 20180531
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61P35/00 ; C12N15/79 ; A61K39/00
Abstract:
The present invention relates to antibodies binding to 5T4, including bispecific antibodies binding to 5T4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.
Public/Granted literature
- US20210070877A1 ANTIBODIES Public/Granted day:2021-03-11
Information query
